Skip to content

Clinical trials

Thromboembolism trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: Canada Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20066
20072
20081
20092
20113
20122
20131
20146
20152
20163
20181
20191
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated3
Unknown status2
Withdrawn2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Boehringer Ingelheim5
Hamilton Health Sciences Corporation3
McMaster University3
Bristol-Myers Squibb2
Daiichi Sankyo2
Janssen Research & Development, LLC2
Ottawa Hospital Research Institute2
St. Joseph's Healthcare Hamilton2
University of Calgary2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism38
Venous Thromboembolism12
Thrombosis11
Venous Thrombosis10
Atrial Fibrillation8
Hemorrhage7
Stroke6
Pulmonary Embolism5
Cardiovascular Diseases3
Embolism and Thrombosis3

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.